Metraipolis › archive › dc_993e4534b1bd
Microbiota and Guillain-Barré syndrome: role of microbial metabolites, biomarkers, and emerging therapeutic strategies — Europe PMC PMID:42111070
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42111070
- DOI
- 10.3389/fneur.2026.1815899
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T19:07:56.907Z
- SHA-256 of the archived text
c97ae3c29b44679d92f021d8c3857beaabd5f807f94c852118d749abb9476195- Stable URL of this page
https://metraipolis.com/documento/dc_993e4534b1bd
How to cite
Microbiota and Guillain-Barré syndrome: role of microbial metabolites, biomarkers, and emerging therapeutic strategies — Europe PMC PMID:42111070 — Europe PMC (en), https://europepmc.org/article/MED/42111070 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_993e4534b1bd (Metraipolis archive dc_993e4534b1bd, sha256 c97ae3c29b44679d92f021d8c3857beaabd5f807f94c852118d749abb9476195)
BibTeX
@misc{dc993e4534b1bd,
title = {Microbiota and Guillain-Barré syndrome: role of microbial metabolites, biomarkers, and emerging therapeutic strategies — Europe PMC PMID:42111070},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42111070},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_993e4534b1bd; sha256 c97ae3c29b44679d92f021d8c3857beaabd5f807f94c852118d749abb9476195},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42111070. Agents can read the archived copy with the MCP tool read_document.